Neurovision
What is Home Computer Vision Therapy (AmbP iNet application)?
AmbP iNet application is used as a complement to personalized occlusion treatment for amblyopia in children between the ages of 4-9.
Recent research supported by the US National Institutes of Health/National Eye Institute reaffirms that the correct method of treatment may be the use of occlusion and/or drops. These new studies recommend covering during visual activities. In this way, hand-eye coordination will be encouraged in the child with amblyopia, which will generally lead to improvement in visual acuity.
This vision aid, which is designed to both help force the amblyopic eye to “see well” and provide more advanced hand-eye coordination. The therapy program strengthens the development of vision by attracting attention with the various activities it includes.
The program will start at the level determined by your ophthalmologist. The program will automatically evaluate your correct and incorrect reactions and the improvement in your vision.
As your or your child's vision improves, the program will automatically switch to a more challenging level. In this way, the patient's performance and the difficulty of the therapy are determined.
Your doctor will inform you which eye will be closed during the treatment. The treatment is applied 5 days a week, 30 minutes each. It is recommended that you work five days a week until your next examination, when your doctor will inform you when you can stop.
MAKE CARE THAT THE DISTANCE BETWEEN YOUR CHILD AND THE SCREEN IS 40 CM. Moving closer to the screen makes the targets appear larger and prevents the work done from achieving its goal.
Neurovision
RevitalVision by NeuroVision™ is used for the treatment of amblyopia (lazy eye) in adults between the ages of 9 and 55. It is a technology that increases visual acuity and contrast acuity by teaching vision directly to the brain through studies using computers and personalized programs.
- The visual stimulations in this application directly stimulate the visual center in the brain and as a result, “Contrast Sensitivity” , Visual Acuity and Quality increases. It is a "non-invasive" vision enhancing treatment based on visual stimulation and stimulation of the neural connections responsible for vision.
- The technology is used in the treatment of adult amblyopia (lazy eye), which has been considered untreatable until now. clinically proven. It also has FDA approval and Medical CE – Mark permission.
- Best-corrected Visual Acuity (BCVA) is expected to increase to 2 ETDRS lines or higher.
- Contrast sensitivity is expected to increase to normal limits. .
- Amblyopia patients may also experience improvement in their binocular functions.
CLICK TO MAKE AN APPOINTMENT WITH OUR EYE DOCTORS
